Alteraciones en el metabolismo glucémico antes y después del tratamiento en pacientes con acromegalia

Colao, 2004, Systemic complications of acromegaly: Epidemiology, pathogenesis, and management, Endocr Rev, 25, 102, 10.1210/er.2002-0022 Katznelson, 2014, Acromegaly: An endocrine society clinical practice guideline, J Clin Endocrinol Metab, 99, 3933, 10.1210/jc.2014-2700 Melmed, 2009, Guidelines for acromegaly management: An update, J Clin Endocrinol Metab, 94, 1509, 10.1210/jc.2008-2421 Alexopoulou, 2014, Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: A study in 148 patients, Pituitary, 17, 81, 10.1007/s11102-013-0471-7 Dreval, 2014, Prevalence of diabetes mellitus in patients with acromegaly, Endocr Connect, 3, 93, 10.1530/EC-14-0021 Fieffe, 2011, Diabetes in acromegaly, prevalence, risk factors, and evolution: Data from the French Acromegaly Registry, Eur J Endocrinol, 164, 877, 10.1530/EJE-10-1050 Kreze, 2001, Risk factors for glucose intolerance in active acromegaly, Braz J Med Biol Res, 34, 1429, 10.1590/S0100-879X2001001100009 Espinosa-de-los-Monteros, 2011, Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism, Pituitary, 14, 231, 10.1007/s11102-010-0284-x Stelmachowska-Banaś, 2009, Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms?, Endokrynol Pol, 60, 20 Clemmons, 2002, Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly, Pituitary, 5, 181, 10.1023/A:1023321421760 Moller, 2009, Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects, Endocr Rev, 30, 152, 10.1210/er.2008-0027 Reid, 2015, IGF-1 levels across the spectrum of normal to elevated in acromegaly: Relationship to insulin sensitivity, markers of cardiovascular risk and body composition, Pituitary, 18, 808, 10.1007/s11102-015-0657-2 Kasayama, 2000, Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients, Clin Endocrinol (Oxf), 52, 549, 10.1046/j.1365-2265.2000.00986.x Varadhan, 2016, The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: A single centre study, Pituitary, 19, 251, 10.1007/s11102-015-0700-3 Arosio, 2012, Predictors of morbidity and mortality in acromegaly: An Italian survey, Eur J Endocrinol, 167, 189, 10.1530/EJE-12-0084 Beauregard, 2003, Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly, Clin Endocrinol (Oxf), 58, 86, 10.1046/j.1365-2265.2003.01679.x Baroni, 2016, Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly, Nutr Metab Cardiovasc Dis, 26, 85, 10.1016/j.numecd.2016.02.001 Jonas, 2016, Evolution of glucose tolerance after treatment of acromegaly: A study in 57 patients, Horm Metab Res, 48, 299, 10.1055/s-0035-1569277 2011, Diagnosis and classification of diabetes Mellitus, Diabetes Care, 34, S62 Puder, 2005, Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly, J Clin Endocrinol Metab, 90, 1972, 10.1210/jc.2004-2009 Dekkers, 2008, Mortality in acromegaly: A meta analysis, J Clin Endocrinol Metab, 93, 61, 10.1210/jc.2007-1191 Holdaway, 2008, A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly, Eur J Endocrinol, 159, 89, 10.1530/EJE-08-0267 Niculescu, 2013, Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly, Pituitary, 16, 168, 10.1007/s11102-012-0396-6 Kinoshita, 2011, Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic beta-cell function is preserved, Eur J Endocrinol, 164, 467, 10.1530/EJE-10-1096